Chemoinformaics analysis of 1,8-Dihydroxy-3,5,7-trimethoxy-2-methylanthraquinone
| Molecular Weight | 344.319 | nRot | 3 |
| Heavy Atom Molecular Weight | 328.191 | nRig | 18 |
| Exact Molecular Weight | 344.09 | nRing | 3 |
| Solubility: LogS | -4.845 | nHRing | 0 |
| Solubility: LogP | 3.669 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 46.3427 |
| nHD | 2 | BPOL | 22.9953 |
| QED | 0.751 |
| Synth | 2.475 |
| Natural Product Likeliness | 1.423 |
| NR-PPAR-gamma | 0.453 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.522 |
| Pgp-sub | 0.01 |
| HIA | 0.384 |
| CACO-2 | -5.208 |
| MDCK | 0.0000158 |
| BBB | 0.015 |
| PPB | 0.924486 |
| VDSS | 0.464 |
| FU | 0.0457313 |
| CYP1A2-inh | 0.454 |
| CYP1A2-sub | 0.97 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.472 |
| CYP2c9-inh | 0.45 |
| CYP2c9-sub | 0.59 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.36 |
| CYP3a4-inh | 0.346 |
| CYP3a4-sub | 0.413 |
| CL | 11.919 |
| T12 | 0.226 |
| hERG | 0.006 |
| Ames | 0.721 |
| ROA | 0.175 |
| SkinSen | 0.183 |
| Carcinogencity | 0.336 |
| EI | 0.911 |
| Respiratory | 0.11 |
| NR-Aromatase | 0.694 |
| Antiviral | Yes |
| Prediction | 0.828473 |